Mordecai Alfred Winborne has made a notable investment in the PRIMECAP Odyssey Discovery ETF by acquiring 50,000 shares, which represents 6.6% of the total outstanding shares. This transaction, completed on October 22, 2026, is significant as it reflects Winborne's confidence in the ETF's potential for growth.
The acquisition took place over two days, with Winborne purchasing 20,000 shares at an average price of $25.69 on October 21, followed by an additional 30,000 shares at an average price of $25.47 the next day. This move may indicate a strategic investment approach, as Winborne aims to capitalize on the ETF market.
Background
Mordecai Alfred Winborne is an investor who has recently filed a Schedule 13D with the SEC regarding his stake in PRIMECAP Odyssey Funds, which is based in Pasadena, California. The company focuses on managing investment funds and has undergone several name changes in the past, with the most recent being in June 2016.
What the Filing Says
The filing states that Winborne's purpose for acquiring the shares is strictly for investment purposes and not to influence control of the PRIMECAP Odyssey Discovery ETF. It notes, “The Reporting Person may seek to acquire additional Shares of POMG and/or may dispose of some or all of their Shares, from time to time.”
Impact
This acquisition may affect the investor community's perception of the PRIMECAP Odyssey Discovery ETF, as Winborne's investment suggests confidence in its future performance. Additionally, it may prompt other investors to consider their positions in the ETF market, particularly in light of Winborne's substantial stake.
What's Next
The filing does not say what happens next.